title: Decompensated heart failure.
abstract: Heart failure is a disease with high incidence and prevalence in the population. The costs with hospitalization for decompensated heart failure reach approximately 60% of the total cost with heart failure treatment, and mortality during hospitalization varies according to the studied population, and could achieve values of 10%. In patients with decompensated heart failure, history and physical examination are of great value for the diagnosis of the syndrome, and also can help the physician to identify the beginning of symptoms, and give information about etiology, causes and prognosis of the disease. The initial objective of decompensated heart failure treatment is the hemodynamic and symptomatic improvement preservation and/or improvement of renal function, prevention of myocardial damage, modulation of the neurohormonal and/or inflammatory activation and control of comorbidities that can cause or contribute to progression of the syndrome. According to the clinical-hemodynamic profile, it is possible to establish a rational for the treatment of decompensated heart failure, individualizing the proceedings to be held, leading to reduction in the period of hospitalization and consequently reducing overall mortality.
authors.forename: Sandrigo
authors.initials: S
authors.lastname: Mangini
authors.forename: Philippe Vieira
authors.initials: PV
authors.lastname: Pires
authors.forename: Fabiana Goulart Marcondes
authors.initials: FG
authors.lastname: Braga
authors.forename: Fernando
authors.initials: F
authors.lastname: Bacal
mesh_terms: D018450:Disease Progression; D006333:Heart Failure / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D006801:Humans; D011379:Prognosis; D012307:Risk Factors